 NEWTON, Mass., Nov. 10, 2020 GLOBE NEWSWIRE -- Acer Therapeutics Inc. Nasdaq: ACER, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2020, and provided an update on the Companys recent corporate developments. 